| 0.632 Data as of Jun 11 |  0.00 / 0.00%Today’s Change | 0.63 Today|||52-Week Range 1.48 | -39.81% Year-to-Date |
| Previous close | 0.63 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 48 |
| Market cap | $18.4M |
| Dividend yield | -- |
| Earnings growth (last year) | -47.46% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 0.17 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$5.0M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer Malcolm L. McColl, PhD, MBA |
Chief Scientific Officer Darren Shafren, PhD |
Corporate headquarters Pymble, New South Wales (nsw) |
.
